RAD140 is actually a non-steroidal selective androgen receptor modulator, or SARM, which emerged from an inner drug discovery program that commenced in 2005. RAD140 has demonstrated strong anabolic activity on muscle mass and bone in preclinical research and concluded 28-day preclinical toxicology research in the two rats and monkeys. Because of it